In the News
Fecal transplants by pill noninferior to colonoscopy delivery
The primary outcome of the unblinded, randomized trial was the proportion of patients without recurrent Clostridium difficile infection 12 weeks after fecal transplant.
Online decision aid may help selection of biologics in IBD
In a survey, 41.3% of respondents with inflammatory bowel disease (IBD) said treatment efficacy was the most important attribute for a biologic, and 53.9% preferred subcutaneous administration at home over IV administration in a clinic.
Factors to predict Barrett's esophagus progression identified in a meta-analysis
Progression was found to be significantly associated with increasing age, male sex, smoking, and increasing segment length, with a low degree of heterogeneity.
MKSAP quiz: Follow-up after ED visit for gallstones
This month's quiz asks readers to determine the most appropriate follow-up for a 41-year-old woman who was diagnosed with gallstones after an ED visit 1 week ago.
Spotlight on drug side effects
One recent study looked at whether NSAID use was linked to incident pancreatic adenocarcinoma, while the other examined acetaminophen-induced hepatotoxicity.
Biosimilar approved for certain cases of breast, metastatic stomach cancer
The drug is the first FDA-approved biosimilar to treat breast or stomach cancer and the second FDA-approved biosimilar to treat cancer.